Investing
Cathie Wood's ARK Invest Sells Over 690,000 Shares of Takeda Pharma
Published:
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 690,000 shares of Takeda Pharmaceutical Co. Ltd. (NYSE: TAK) on Tuesday, as the share price of this fund traded was up 2% in the day’s session. Its share price has greatly improved over the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 692,660 shares of Takeda. At Tuesday’s closing price, this would have valued this sale at roughly $9.8 million. This is only a small fraction of the total holdings. This fund is flat over the past 52 weeks.
Here is a quick look at all the other sales that took place across all ARK ETFs:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | OPEN | OPENDOOR TECHNOLOGIES | 166,353 |
| ARKF | Z | ZILLOW | 123,790 |
| ARKG | INCY | INCYTE | 6,219 |
| ARKG | TAK | TAKEDA PHARMACEUTICAL | 692,660 |
| ARKG | VEEV | VEEVA SYSTEMS | 31,755 |
| ARKQ | LMT | LOCKHEED MARTIN | 4,885 |
| ARKQ | U | UNITY SOFTWARE | 11,000 |
| ARKW | U | UNITY SOFTWARE | 112,381 |
| ARKX | HOFP | THALES | 15,040 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
